SEC Form 4 · accession 0000899243-16-020802
PROTHENA CORP PUBLIC LTD CO · PRTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Karl Anders Olof Harfstrand
Director
Period of report
May 20, 2016
Accepted (ET)
May 24, 2016 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559053
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $42.50 | May 20, 2016 | A | 15,000 | A | — | May 20, 2026 | Ordinary Shares | 15,000 | 15,000 | D |
Explanation of responses
- F1The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2017 of the Issuer's shareholders, assuming continuous service as a director until such vesting date.